Europe — EMA
Natriumhydrogenkarbonat B. Braun (Sodium Hydrogen Carbonate)
GNH USA supplies Natriumhydrogenkarbonat B. Braun (Sodium hydrogen carbonate), a IV solvent/buffer for metabolic acidosis and surgical buffering.
Request sourcing
What is Sodium Hydrogen Carbonate?
Sodium hydrogen carbonate, the active ingredient in Natriumhydrogenkarbonat B. Braun, is an excipient presented as a sterile solution for intravenous use. It provides bicarbonate ions to buffer blood pH and is employed to correct metabolic acidosis in patients receiving IV therapy.
GNH USA supplies Natriumhydrogenkarbonat B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Sodium Hydrogen Carbonate used for?
Natriumhydrogenkarbonat B. Braun is used as an intravenous buffering agent to manage acid‑base disturbances in several clinical settings.
- Metabolic acidosis: restores normal blood pH by supplying bicarbonate ions. - Cardiac surgery: mitigates intra‑operative acidemia and supports hemodynamic stability. - Renal replacement therapy: maintains systemic bicarbonate levels during dialysis procedures.
What are the side effects of Sodium Hydrogen Carbonate?
Adverse reactions may occur with intravenous administration of sodium bicarbonate solutions.
Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Metabolic alkalosis: excessive rise in blood pH. - Hypokalemia: reduced serum potassium concentration. - Fluid overload: increased intravascular volume. - Hypertension: elevated blood pressure due to volume expansion. - Transient erythema at infusion site.
Serious or Rare Side Effects: - Pulmonary edema: accumulation of fluid in the lungs. - Cardiac arrhythmias: irregular heart rhythms associated with electrolyte shifts. - Severe hypervolemia: dangerous fluid overload leading to organ dysfunction. - Cerebral edema: swelling of brain tissue in extreme cases. - Acute kidney injury: impaired renal function from electrolyte disturbances.
What precautions apply to Sodium Hydrogen Carbonate?
Proper clinical assessment and monitoring are essential when using this intravenous buffer.
- Electrolyte monitoring: regularly check serum sodium, potassium, and bicarbonate levels. - Acid‑base assessment: evaluate arterial blood gases before and after infusion. - Renal impairment: adjust dosage or avoid rapid infusion in patients with reduced kidney function. - Cardiac disease: use caution in patients with heart failure or hypertension. - Infusion rate: avoid rapid bolus administration to reduce risk of alkalosis. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.
What does Sodium Hydrogen Carbonate interact with?
Sodium hydrogen carbonate can influence the activity of several co‑administered drugs.
Major Interactions (Avoid): - Calcium chloride: precipitation risk when mixed in the same solution. - Other alkalinizing agents (e.g., sodium acetate): may cause excessive alkalosis. - Certain antibiotics (e.g., aminoglycosides): reduced efficacy due to altered pH.
Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate hypokalemia. - ACE inhibitors or ARBs: increased risk of hyperkalemia when combined with potassium‑sparing effects. - Anticoagulants: pH changes can affect clotting factor activity. - Anticonvulsants (e.g., phenytoin): altered plasma protein binding. - Insulin: may require dose adjustment due to changes in potassium distribution.



